Filters in anaesthesia and intensive care

Anaesthesia and Intensive Care

Volumn 31, Issue 4, 2003, Pages 418-433

  Tyagi, A ^a   Kumar, R ^a   Bhattacharya, A ^b   Sethi, A K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b SIR GANGA RAM HOSPITAL   (India)

Author keywords

Epidurial: filter; Filters; Filters: breathing system filters, blood filters, leucocyte depleting filter, microfilter, in line filters; Intensive care

Indexed keywords

ADENINE; AMPHOTERICIN B; BRADYKININ; CITRIC ACID; COMPLEMENT COMPONENT C3; CYTOTOXIC AGENT; DAUNORUBICIN; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ENDOTOXIN; FENTANYL; FIBRONECTIN; GLUCOSE; HLA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFUSION FLUID; ISOSORBIDE 5 NITRATE; MANNITOL; METHOTREXATE; MITOXANTRONE; NITROUS OXIDE PLUS OXYGEN; PHENOBARBITAL; PHOSPHATE; SODIUM CHLORIDE; VANCOMYCIN;

AIR CONDITIONING; ALLOIMMUNIZATION; ANESTHESIA; BACTERIUM CONTAMINATION; BLOOD FILTER; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BREATHING APPARATUS; CLINICAL PRACTICE; COMPLEMENT ACTIVATION; CROSS INFECTION; CYTOMEGALOVIRUS; ENDOTRACHEAL INTUBATION; EPIDURAL CATHETER; FEVER; FILTER; FOREIGN BODY; HEMOLYSIS; IMMUNOMODULATION; INFECTION RISK; INTENSIVE CARE; LEUKOPENIA; MEDICAL LITERATURE; PHLEBITIS; PRACTICE GUIDELINE; RECIPIENT; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEPTICEMIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMODYNAMICS; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; VIRUS TRANSMISSION; WARMING;

ANESTHESIOLOGY; FILTRATION; HEMOFILTRATION; HUMANS; INTENSIVE CARE; MICROPORE FILTERS; ULTRAFILTRATION;

EID: 0041922644     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (183)

1. Hogarth I. Anaesthetic machine and breathing system contamination and the efficacy of bacterial and viral filters. Anaesth Intensive Care 1996; 24:154-163.
2. Das I, Fraise AP. How useful are microbial filters in respiratory apparatus. J Hosp Infect 1997; 37:263-272.
3. Kapadia F, Valentine S, Smith G. The role of blood microfilters in clinical practice. Intensive Care Med 1992; 18:258-263.
4. Fantus B. The Cook County's blood bank. Mod Hosp 1938; 50:57-58.
5. Telischi M. Evolution of Cook County Hospital Blood Bank. Transfusion 1974; 14:623-628.
6. Snyder EL, Bookbinder M. Role of microaggregate blood filtration in clinical medicine. Transfusion 1983; 23:460-470.
7. Stack G, Judge JV, Synder EL. Febrile and Nonimmune Transfusion Reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine, 2nd Ed. Williams & Wilkins, 1996; 773-784.
8. Griffith EM. Microfiltration of stored blood regardless of age of storage. Lancet 1977; 1:1010.
9. Solis RT, Walker BD. Does a relationship exist between massive BT and the adult RDS? If so, what are the best preventive measures? Vox Sang 1977; 32:319-320.
10. Barrett J, Tahir AH, Litwin MS. Increased pulmonary arteriovenous shunting in humans following blood transfusion. Arch Surg 1978; 113:947-950.
11. Takaori M, Nakajo N, Ishii T. Changes of pulmonary function following transfusion of stored blood. Transfusion 1977; 17:615-620.
12. Lloyd GM, Marshall L. Blood microaggregates, their role in transfusion reactions. Intens Care Worl 1986; 3:119-122.
13. Brown PJ. Compatibility testing. In: Rudmann SV, ed. Textbook of Blood Banking and Transfusion Medicine. W. B. Saunders Company, Philadelphia 1995; 282-309.
14. Bolton DT, Peeters A. Microaggregates and filtration. Correspondence. Anaesthesia 1998; 43:330-331.
15. Robertson M, Boulton F, Doughty R et al. Microaggregate formation in optimum additive red cells. Vox Sang 1985; 49:259-266.
16. Gulliksson H, Karlman G, Segerlind A, Gullbring B. Preservation of red blood cells: content of microaggregates and di-2-ethylhexylphthalate (DEHP) in red blood cells stored in saline-adenine-glucose-mannitol (SAGM) medium. Vox Sang 1986; 50:16-20.
17. Perkins HA, Payne R, Ferguson J, Wood M. Non haemolytic febrile transfusion reactions. Quantitative effect of blood components with emphasis on isoantigenic incompatibility of leucocytes. Vox Sang 1966; 11:578-600.
18. Mollison PL. Blood transfusion in clinical medicine, 6th edition. Blackwell P, 1033.
19. Wenz B, Gurtlinger KF, O'Toole AM, Dugan EP. Preparation of Granulocyte-Poor Red Blood Cells by microaggregate filtration. A Simplified Method to minimize febrile transfusion reactions. Vox Sang 1980; 39:282-287.
20. Parravicini A, Rebulla P, Apuzzo J, Wenz B, Sirchia G. The preparation of leucocyte poor red cells for transfusion by a simple cost effective technique. Transfusion 1984; 24:508-509.
21. Sirchia G, Wenz B, Rebulla P, Paravicini A, Carnelli V, Bertolini F. Removal of white cells from red cells by transfusion through a new filter. Transfusion 1990; 30:30-33.
22. Reul GJ, Beal AC, Greenberg S. Protection of the pulmonary vasculature by fine screen blood filtration. Chest 1974; 66:4-9.
23. Reul GJ, Greenberg SD, Lefrak EA. Prevention of post traumatic pulmonary insufficiency by fine screen filtration of blood. Arch Surg 1973; 106:386-394.
24. Folwer AA, Hamman RF, Good JT et al. Adult Respiratory Distress Syndrome: Risk with common predispositions. Ann Int Med 1983; 98:593-597.
25. Bisio JM, Connell RS, Harrison MW. The formation and effect of stored platelet concentrate microemboli on pulmonary ultrastructure. Surg Gynecol Obstet 1982 Mar; 154:342-347.
26. Goldiner PL, Howland WS, Ray C. Filter for prevention of microembolism during massive transfusion. Anesth Analg 1972; 51:717-725.
27. Loong ED. Microfiltration of stored blood. Anaesth Intensive Care 1980; 2:158-161.
28. Bredenberg CE. Microaggregate filters. Int Anesthesiol Clin 1982; 20:195-205.
29. Bareford D, Chandler ST, Hawker RJ, Jackson N, Smith M, Boughton BJ. Splenic platelet-sequestration following routine blood transfusion is reduced by filtered/washed blood products. Br J Haem 1987; 67:177-180.
30. Hart S, Bareford D, Smith N, MacWhannel, Lanchbury E, Boughton B. Post-transfusion thrombocytopenia: its duration in splenic and asplenic individuals. Vox Sang 1990; 59:123-124.
31. Monnucci M, Federici AB, Sirchia A. Haemostasis testing during massive blood replacement. Vox Sang 1982; 42:113-132.
32. Lim S, Boughton BJ, Bareford D. Thrombocytopenia following routine blood transfusion: micro-aggregate blood filters prevent worsening thrombocytopenia in patients with low platelet counts. Vox Sang 1989; 56:40-41.
33. Saba TM, Jaffe E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 1980; 68:577-594.
34. Frewin DB, Jonsson JR, Davis KB et al. Effect of microfiltration on the histamine levels in stored human blood. Vox Sang 1987; 52:191-194.
35. Dunbar RW, Price KA, Cannarella CF. Microaggregate blood filters: effect on filtration time, plasma haemoglobin and fresh blood platelet counts. Anesth Analg 1974; 53:577-583.
36. Buley R, Lumley G. Some observations on blood microfilters. Ann Coll Surg Engl 1975; 57:262-267.
37. Langhurst DM, Gooch WM, Castello RA. In vitro evaluation of a paediatric microaggregate blood filter. Transfusion 1983; 23:170-177.
38. Schmidt WF, Kim HC, Schwartz E, Tomassini N. RBC destruction caused by a micropore blood filter. J Am Med Assoc 1982; 248:1629-1632.
39. Linko GE. Microaggregate filters and neonate patients. Transfusion 1983; 23:537-548.
40. Czika A, Klose R. Flow measurement in blood filters. Infusionsther Klin Ernahr 1981; 8:181-183.
41. Linko K. In-line blood warming and micro-filtration devices II. Influenze of blood temperature on flow rate and hemolysis during transfusion through microfilters and transfusion sets. Acta Anaesthesiol Scand 1979; 1:46-50.
42. Derrington C. The present status of blood filtration. Anaesthesia 1985; 40:334-347.
43. Snyder EL, Mezzey A, Cooper-Smith M, Jones R. Effects of microaggregate blood filtration on platelet concentrated in vitro. Transfusion 1983; 21:427-434.
44. Yellon RF, Vernick S, Golub AH. Complement activation by blood micro-filters (abstract). Transfusion 1981; 21:610-611.
45. Snyder EL, Root RK, McLeod B, Dalmasso AP. Activation of complement by blood transfusion filters. Vox Sang 1983; 45:288-293.
46. Yellon RF, Vernick S, Golub A. Effect of blood microfilters on complement activity in human plasma. Biomat Med Devices Artif Organs 1983; 11:237-245.
47. Dhurandhur HN, Brown C, Barrett J, Litwin S. Pulmonary structural changes following microembolism and blood transfusions. Arch Pathol Lab Med 1979; 103:335-340.
48. Walsh RL, Coles ME. Binding of IgG and other proteins to microfilters. Clin Chem 1980 Mar; 26:496-498.
49. Faust RJ, Harrison CR, Stehling LC. Questions and Answers about Transfusion Practices, 3rd Ed. American Society of Anesthesiologists.
50. Danish Society of Clinical Immunology. Danish recommendations for the transfusion of leukocyte-depleted blood components. Vox Sang 1996; 70:185-186.
51. Dzik WH. Leukoreduced Products. In: Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, eds. Handbook of Transfusion Medicine. Academic Press, UK, 2001; 125-128.
52. British Committee on standards in Haematology. Guidelines on the clinical use of leucocyte-depleted blood components. Transfus Med 1998; 8:59-71.
53. Heddle NM, Klama L, Singer J et al. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625-628.
54. Goodnough LT, Riddell J, Lazarus H et al. Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration. Vox Sang 1993; 65:103-107.
55. Mangano MM, Chambers LM, Kruskall MS. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 1991; 95:733-738.
56. Lane T, Anderson K, Goodnough et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992; 117:151-162.
57. Freedman J, Blajchman M, McCombie N. Canadian Red Cross Society Symposium on leukodepletion. Report of proceedings. Transfus Med Rev 1994; 8:1-14.
58. Heddie N. The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies. Transfus Med Rev 1994; 8:15-28.
59. Klein HG, Dzik S, Slichter SJ et al. Leukocyte-reduced blood components: Current status. Washington, DC: Am Soc Hematol 1998; 39-62.
60. Trial to Reduce Alloimmunization to Platelets (TRAP) Study Group. Leucocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion. N Engl J Med 1997; 337:1861-1869.
61. Wilkinson SL, Lipton KS. Leukocyte Reduction. Am Ass Bld Bank Bulletin 1999; #99-7.
62. Hiruma K, Okuyama Y. Effect of leucocyte reduction on the potential alloimmunogenicity of leucocytes in fresh-frozen plasma products. Vox Sang 2001 Jan; 80:51-56.
63. Blajchman MA, Vamvakas S, eds. Immunomodulation and Blood Transfusion. AABB Press, Bethesda, MD 1999.
64. Jensen LS, Kissmeyer Nielsen P, Wolff B, Qvist N. Randomized comparison of leucocyte depleted verus buffy coat poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-847.
65. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-466.
66. Van de Watering LMT, Hermans J, Houbiers JGA et al. Beneficial effects of leukocyte depletion on transfused blood on postoperative complications in patients undergoing heart surgery. A randomized clinical trial. Circulation 1998; 97:562-568.
67. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet? (Editorial). Transfusion 1997; 37:121-125.
68. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: Meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36:175-186.
69. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies. Br J Surg 1998; 85:171-178.
70. Dzik WH. Leukoreduced blood components: Laboratory and clinical aspects. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion medicine, 2nd Ed. Williams & Wilkins, Baltimore 1996; 353-374.
71. Hillyer CD, Emmens RK, Zago Novaretti M, Berkman EM. Methods for the reduction of transfusion transmitted cytomegalovirus infection: Filtration versus the use of seronegative donor units. Transfusion 1994; 34:929-934.
72. Hillyer CD, Lankford KV, Roback JD, Gillespie TW, Silberstein LE. Transfusion of the HIV seropositive patient: Immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5) and HHV-6, 7 and 8. Transfusion Med Rev 1999; 13:1-17.
73. Lipson SM, Shepp DH, Match ME, Axelrod FB, Whitbread JA. Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration. Am J Clin Pathol 2001; 116:52-55.
74. Brown KA, Lewis SM, Hill TA et al. Leucodepletion and the interaction of polymorphonuclear cells with endothelium in systemic inflammatory response syndrome. Perfusion 2001; Mar 16 Suppl:75-83.
75. Hogman C, Gong J, Hambraeus A et al. The role of white cells in the transmission of Yersinia enterocolitica in blood components. Transfusion 1992; 32:654-657.
76. Kim D, Brecher M, Bland L et al. Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters. Transfusion 1992; 32:658-662.
77. Wenz B, Burns E, Freundlich L. Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration. Transfusion 1992; 32:663-666.
78. Bucholtz D, AuBuchon J, Snyder E et al. Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion 1992; 32:667-672.
79. Franzin I, Gioannini P. Growth of Yersinia species in artificially contaminated blood bags. Transfusion 1992; 32:673-676.
80. Nusbacher J. Yersinia enterocolitica and white cell filtration. Transfusion 1992; 32:597-600.
81. Heal J, Cohen H. Do white cells in stored blood components in blood components reduce the likelihood of posttransfusion bacterial sepsis? Editorial. Transfusion 1991; 31:581-582.
82. Chitiyo ME. Hypotension and bedside leukocyte reduction filters. Cent Afr J Med 1999; 45:164.
83. Zoon KC, Jacobson ED, Woodcock J. Leukocyte reduction filters may cause hypotension. Clin J Oncol Nurs 1999; 3:94-95.
84. Zoon KC, Jacobson ED, Woodcock J. Hypotension and bedside leukocyte reduction filters. Int J Trauma Nurs 1999; 5:121-122.
85. Cardigan R, Sutherland J, Garwood M, et al. The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001; 114:233-240.
86. Uoshima N, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Anaphylaxis in a myelodysplastic syndrome patient during platelet transfusion with a leukocyte-reduction filter. Rinsho Ketsueki 1998; 39:614-616.
87. Trautmann M, Zauser B, Wiedeck H, Buttenschon K, Marre R. Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect 1997; 37:225-236.
88. Newall F, Ranson K, Robertson J. Use of in-line filters in pediatric intravenous therapy. J Intraven Nurs 1998; 21:166-170.
89. Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann Pharmacother 1994; 28:11-16.
90. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis. Its prevention by in-line filtration. N Engl J Med 1985; 312:78-82.
91. Hessov I. Prevention of infusion thrombophlebitis. Acta Anaesthesiol Scand 1985; 82 (Suppl):33-37.
92. Richards C, Millar-Jones L, Alfaham M. Assessment of in-line filters to prolong the life of intravenous cannulae in cystic fibrosis patients. J Clin Pharm Ther 1995; 20:165-166.
93. Stromberg C, Wahlgren J. Saving money with effective in-line filters. Intensive Care Nurs 1989; 5:109-113.
94. Sabon RL Jr, Cheng EY, Stommel KA, Hennen CR. Glass particle contamination: influence of aspiration methods and ampule types. Anesthesiology 1989; 70:859-862.
95. Hirakawa M, Makino K, Nakashima K, Kataoka Y, Oishi R. Evaluation of the in-line filters for the intravenous infusion of amphotericin B fluid. J Clin Pharm Ther 1999; 24:387-392.
96. De Muynck C, De Vroe C, Remon JP, Colardyn F. Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units. J Clin Pharm Ther 1988; 13:335-340.
97. Stevens RF, Wilkins KM. Use of cytotoxic drugs with an end-line filter - a study of four drugs commonly administered to paediatric patients. J Clin Pharm Ther 1989; 14:475-479.
98. Bohrer H, Zhang CH, Krier C. Decrease in the concentration of tobramycin, vancomycin and phenobarbital in administration with infusion filter. Infusionsther 1991; 18:96-100.
99. De Muynck C, Vandenbossche GM, Colardyn F, Remon JP. The sorption of isosorbide-5-mononitrate to intravenous delivery systems. J Pharm Pharmacol 1990; 42:433-434.
100. Rapp RP, Bivins BA. Final in-line filtration: removal of contaminants from IV fluids and drugs. Hosp Formul 1983; 18:1124-1128.
101. Hauer T, Dziekan G, Kruger WA, Ruden H, Daschner F. Reasonable and unreasonable hygiene measures in anesthesia in the intensive care unit. Anaesthesist 2000; 49:96-101.
102. Driscoll DF, Bacon MN, Bistrian BR. Effects of in-line filtration on lipid particle size distribution in total nutrient admixtures. J Parenter Enteral Nutr 1996; 20:296-301.
103. Richards C, Grassby PF. A comparison of the endotoxin-retentive abilities of two '96-h" in-line intravenous filters. J Clin Pharm Ther 1994; 19:199-202.
104. Kanefield JK, Munro JT, Eisele JH. Incidence of bleeding after oral endotracheal intubation. Anesthesiol Rev 1990; XVII:43-45.
105. Kristensen MS, Sloth E, Jensen TK. Relationship between anesthetic procedure and contact of anesthesia personnel with body fluids. Anesthesiol 1990; 73:619-624.
106. Boucek CD. Blood in the mouth. N Eng J Med 1988; 319:1607.
107. Luttropp H, Berntman L. Bacterial filters protect anaesthetic equipment in a low flow system. Anaesthesia 1993; 48:520-523.
108. Shiotani G, Nicholes P, Ballinger C, Shaw L. Prevention of contamination of the circle system and ventilators with a new disposable filter. Anesth Analg 1971; 50:844-855.
109. du Moulin G, Saubermann AJ. The anaesthesia machine and circle system are not likely to be sources of bacterial contamination. Anaesthesiology 1977; 47:353-358.
110. Murphy P, Fitzgeorge R, Barrett R. Viability and distribution of bacteria after passage through a circle anaesthetic system. Br J Anaesth 1991; 63:300-304.
111. MacCallum F, Nobel W. Disinfection of anaesthetic face masks. Anaesthesia 1960; 15:307.
112. Langevin PB, Rand KH, Layon AJ. The potential for dissemination of Mycobacterium tuberculosis through the anesthesia breathing circuit. Chest 1999; 115:1107-1114.
113. Pandit S, Mehta S, Agarwal S. Risk of cross infection from inhalation anaesthetic equipment. Br J Anaesth 1967; 39:838-844.
114. Craven D, Driks M. Nosocomial pneumonia in the intubated patient. Seminars Respir Infect 1987; 2:20-30.
115. Craven D, Goularte T, Make B. contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? Am Rev Resp Dis 1984; 129:825-828.
116. Malecka-Griggs B, Reinhardt D. Direct dilution sampling quantitation and microbial assessment of open-system ventilation circuits in Intensive Care Units. J Clin Microbiol 1983; 17:870-877.
117. Nielson H, Vasegaard M, Stokke D. Bacterial contamination of anaesthetic equipment. Br J Anaesth 1978; 50:811-814.
118. Nielson H, Hacobsen J, Stokke D, Brinklov M, Christensen K. Cross-infection from contaminated anaesthetic equipment. A real hazard? Anaesthesia 1980; 35:703-708.
119. Leijten DTM, Rejger VS, Mouton RP. Bacterial contamination and the effect of filters in anaesthetic circuits in a simulated patient model. J Hosp Infect 1992; 21:51-60.
120. du Moulin GC, Hedley-Whyte J. Bacterial interactions between anesthesiologists, their patients, and equipment. Anesthesiology 1982; 57:37-41.
121. Ibrahim J, Perceval A. Contamination of anaesthetic tubing: a real hazard? Anaesth Intensive Care 1992; 20:317-321.
122. Stemmermann MG, Stern A. Tubercle bacilli in the metabolic apparatus. Ann Rev Tuberculosis 1946; 53:264-266.
123. Zeigler C, Jacoby J. Anaesthetic equipment as a source of infection. Anesth Analg 1956; 35:451-459.
124. Duigood JP. Expulsion of pathogenic organisms from the respiratory tract. Br Med J 1946; 1:265-268.
125. Sattar SA, Ijaz MK. Spread of viral infections by aerosols. CRC Critical Rev in Environmental Control 1987; 17:89-131.
126. Phillips I, Spencer G. Pseudomonas aeruginosa cross infection due to contaminated respiratory apparatus. Lancet 1965; ii:1325-1327.
127. Seal D, Strangeways J. Epidemiology and prevention of Pseudomonas aeruginosa chest infection in an Intensive Care Unit. Anaesth Intensive Care 1981; 9:260-265.
128. Tinnie JE, Gordon AM, Bain WH, Mackey WA. Cross infection by pseudomonas aeruginosa as a hazard of intensive surgery. Br Med J 1967; 4:313-315.
129. Olds J, Kisch A, Eberle B. Wilson J. Pseudomonas aeruginosa respiratory tract infection acquired from a contaminated anesthesia machine. Am Rev Resp Dis 1972; 105:628-632.
130. Gallagher J, Strangeways JEM, Alt-Graham J. Contamination control in long-term ventilation. Anaesthesia 1987; 42:476-481.
131. Fluornoy DJ, Plumlee CJ, Steffee RE. Volume ventilator as a vehicle of airborne bacterial contamination from patients. Respir Care 1980; 25:742-744.
132. Redding PI, McWalter PW. Pseudomonas fluorescens cross infection due to contaminated humidified water. Br Med J 1980; 281:275-282.
133. Perea EJ, Criado A, Moreno M et al. Mechanical ventilation as vehicles of infection. Acta Anaesthesiol Scand 1975; 19:180-186.
134. Albrecht WH, Dryden GE. Five-year experience with the development of an individually clean anesthesia system. Anesth Analg 1974; 53:24-28.
135. Feeley TW, Hamilton WK, Xavier B, Moyers J, Eger E. Sterile anesthesia breathing circuits do not prevent postoperative pulmonary infection. Anesthesiology 1981; 54:369-372.
136. Garibaldi R, Britt M, Webster C, Pace N. Failure of bacterial filters to reduce the incidence of pneumonia after inhalation anesthesia. Anesthesiology 1981; 54:364-368.
137. Atkinson MC, Girgis Y, Broome IJ. Extent of practicalities of filter use in anaesthetic breathing circuits and attitudes towards their use: a postal survey of UK hospitals. Anaesthesia 1999; 54:37-41.
138. Alfieri N, Armstrong P. Patient circuit components of anaesthetic equipment between uses on different patients. Letter. Can J of Infect Control 1995; 10:61.
139. Inglis TJJ, Sproat LJ, Hawkey PM, Knappett P. Infection control in intensive care units: UK national survey. Br J Anaesth 1992; 68:16-220.
140. Martin C, Perri G, Gevandon MJ, Saux P, Gain F. Heat and moisture exchangers and vaporising humidifiers in the intensive care unit. Chest 1990; 97:144-149.
141. Kirton O, De Haven B, Morgan J, Morejon O. A prospective randomised comparison of an in line heat and moisture exchanger filter and heated wire humidifier. Chest 1997; 112:1055-1059.
142. Pottecher B, Eherhardt R, Kieny MT et al. Evaluation of the cost-efficacy ratio of Pall BB 22 15 filters for the bacterial protection of anesthesia circuits. Agressologie 1990; 31:553-556.
143. Callery S, Jaskolka J, Holwerda A, Groves D. Safety and cost effectiveness of filter protected, multiuse anaesthetic circuits. CHICA-Canada, National Education Conference (abstract). Can J Infect Control 1996; 11:75.
144. Rathgeber J, Kietzmann D, Mergeryan H, Hub R, Zuchner K, Kettler D. Prevention of patient bacterial contamination of anaesthesia-circle systems: a clinical study of contamination risk and performance of different heat moisture exchangers with electret filter (HMEF). Eur J Anaesthesiol 1997; 14:368-373.
145. Vezina DP, Trepanier CA, Lassard MR, Gourdeau M, Tremblay C. Anesthesia breathing circuits protected by the DAR Barrierbac S® breathing filter have a low bacterial contamination rate. Can J Anesth 2001; 48:748-754.
146. Memish ZA, Oni GA, Djazmati W, Cunningham G, Mah MW. A randomized clinical trial to compare the effects of a heat and moisture exchanger with a heated humidifying system on the occurrence rate of ventilator-associated pneumonia. Am J Infect Control 2001; 29:301-305.
147. van Hassel S, Laveaux M, Leenders M, Kaan JA, Mintjes J. Bacterial filters in anesthesia: results of 9 years of surveillance. Infect Control Hosp Epidemiol 1999; 20:58-60.
148. Hardman JG, Curran J, Mahajan RP. End tidal carbon dioxide measurements and breathing system filters. Anaesthesia 1997; 52:646-648.
149. Costigan SN, Snowdon SL. Breathing system filters can affect the performance of anaesthetic monitors. Anaesthesia 1993; 48:1015-1016.
150. McEwan AI, Dowell L, Karis JH. Bilateral tension pneumothorax caused by a blocked bacterial filter in an anesthesia breathing circuit. Anesth Analg 1993; 76:440-442.
151. Smith CE, Otworth JR, Kaluszyk P. Bilateral tension pneumothorax due to a defective anesthesia breathing circuit filter. J Clin Anesth 1991; 3:229-234.
152. Australian Therapeutic Goods Administration. Heat and moisture exchange filter obstruction. Australian Therapeutic Device Bulletin 1990; 903.
153. Lawler PG. Inhalational formaldehyde vapours. A potential hazard of a method of sterlisation of bacterial of bacterial filters. Anaesthesia 1982; 37:1102-1103.
154. Wilkes AR. The ability of breathing system filters to prevent liquid contamination of breathing systems: a laboratory study. Anaesthesia 2002; 57:33-39.
155. Fargnoli JM, Arvieux CC, Coppo F, Girardet P, Eisele Jh Jr. Efficiency and importance of airway filters in reducing microorganisms (abstract). Anesth Analg 1992; 74:S93.
156. Hedley RM, Alt Graham J, A comparison of the filtration properties of heat and moisture exchangers. Anaesthesia 1992; 47:414-420.
157. Lee MG, Ford JL, Hunt PB, Ireland DS, Swanson PW. Bacterial retention properties of heat and moisture exchange filters. Br J Anaesth 1992; 69:522-525.
158. Mebius C. Heat and moisture exchangers with bacterial filters: a laboratory evaluation. Acta Anaesth Scand 1992; 36:572-576.
159. Holton J, Webb AR. An evaluation of microbial retention performance of three ventilator-circuits filters. Intens Care Med 1994; 20:233-237.
160. Vandenbroucke-Grauls CMJE, Teeuw KB, Ballemans K, Lavooij C, Correlisse PB, Verhoef J. Bacterial and viral removal efficiency. Heat and moisture exchange properties of four filtration devices. J Hosp Infect 1995; 29:45-56.
161. Wilkes AR, Benbough JE, Speight SE, Harmer M. The bacterial and viral filtration performance of breathing system filters. Anaesthesia 2000; 55:458-465.
162. National Institute for Occupational Safety and Health (NIOSH). Respiratory protective devices. Code of Federal Regulations, Title 42, Part 84. Morgantown, West Virginia, USA: National Institute for Occupational Safety and Health, 1995.
163. British Standards Institution. Breathing system filters for anaesthetic and respiratory use - Part 1: test method to assess filtration performance (draft prEN 13328-1: 2001). Milton Keynes, UK: British Standards Institution, 2001.
164. American Society of Anesthesiologists. Committee on occupational health of operating room personel. Recommendations for infection control for the practice of anaesthesiology. 2nd ed, American Society of Anesthesiologists, Park Ridge, IL 1998.
165. Public health service centres for disease control. Guidelines for prevention of nosocomial pneumonia. MMWR 1997; 46 (RR-1):1-79.
166. Laboratory centre for disease control. Infection control guidelines. Hand washing, cleaning disinfection and sterilization in health care. Canada communicable disease report 1998; 24 S8:10-26.
167. Association of Anaesthetists of Great Britain and Ireland. A report received by council of association of Anaesthetists on blood borne viruses and anaesthesia - An update. January 1996.
168. Chant K, Kociuba K, Munro R et al. Investigation of possible patient-to-patient transmission of Hepatitis C in a hospital. New South Wales Public Health Bulletin 1994; 5:47-51.
169. Barreto SR. Bacteriological cultures of indwelling epidural catheters. Anesthesiology 1962; 23:643-646.
170. Hunt JR, Rigor BM, Collins JR. The potential for contamination of continuous epidural catheters. Anesth Analg 1977; 56:222-225.
171. Du Pen SL, Peterson DG, Williams A, Bogosian AJ. Infection during chronic epidural catheterization: Diagnosis and treatment. Anesthesiology 1990; 73:905-909.
172. Abouleish E, Amortegui AJ, Taylor FH. Are bacterial filters needed in continuous epidural analgesia for obstetrics? Anesthesiology 1977; 46:351-354.
173. James FM, George RH, Naiem H, White GJ. Bacteriologic aspects of epidural analgesia. Anesth Analg 1976; 55:187-190.
174. Foldes ff, McNall PC. 2-chloroprocaine: New local anesthetic agent. Anesthesiology 1952; 13:287-296.
175. Mercadante S. Neuraxial Techniques for cancer pain: An opinion about unresolved therapeutic dilemmas. Reg Anesth Pain Med 1999; 24:74-83.
176. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999; 79:1-13.
177. Nitescu P, Sjoberg M, Appelgren L, Curelau I. Complications of intrathecal opioids and bupivacaine in treatment of refractory cancer pain. Clin J Pain 1995; 11:45-62.
178. Crawford JS, Williams ME, Veales S. Particulate matter in the extradural space (Letter). Br J Anaesth 1975; 47:807.
179. Abouleish E, Orig T, Amortegui AJ. Bacteriologic comparison between epidural and caudal techniques. Anesthesiology 1980; 53:511-514.
180. De Cicco M, Matovic M, Castellani GT et al. Time-dependent efficacy of bacterial filters and infection risk in long-term epidural catheterization. Anesthesiology 1995; 82:765-771.
181. Avidan MS, Jones N, Ing R, Khoosal M, Lundgren C, Morrell DF. Convection warmers - not just hot air. Anaesthesia 1997; 52:1073-1076.
182. Chilvers RI, Wiesz M. Entonox equipment as a potential source of cross-infection. Anaesthesia 2000; 55:176-179.
183. Bajekal RR, Turner R, Yentis SM. Anti-infective measures and Entonox equipment - a survey. Anaesthesia 2000; 55:153-154.